News Daily News Some Daylight for Vitamin D? New Analysis Hints at Small CVD Benefit Michael O'Riordan June 30, 2023
News Conference News ADA 2023 Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide L.A. McKeown June 28, 2023
News Daily News Aspirin Use Ups Risk of Anemia in Elderly Patients: ASPREE Michael O'Riordan June 22, 2023
News Daily News Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism Caitlin E. Cox June 16, 2023
News Daily News Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2 Michael O'Riordan June 14, 2023
News Daily News Patients Most Vulnerable to CVD the Least Likely Use Wearable Devices Caitlin E. Cox June 13, 2023
News Conference News SCAI 2023 CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI L.A. McKeown May 25, 2023
News Conference News SCAI 2023 Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI L.A. McKeown May 24, 2023
News Daily News REPRIEVE Stopped: Big MACE Reductions With Statins in HIV+ Subjects Shelley Wood April 12, 2023
News Daily News Inactivity Pandemic Poised to Undo CVD Prevention Advances Michael O'Riordan April 11, 2023
News Daily News Third-Trimester Preeclampsia Screening Still Worthwhile, Data Suggest Caitlin E. Cox April 11, 2023
News Daily News AHA Urges Holistic Cardiovascular Care of Women, With Focus on Race/Ethnicity Yael L. Maxwell April 10, 2023
News Daily News Severe Infections Linked to a Variety of CV Events, Both Acute and Long-term Caitlin E. Cox March 28, 2023
News Daily News MI Risk in Subclinical CAD? Both Extent and Stenosis Severity Matter Yael L. Maxwell March 27, 2023
News Daily News Pregnancy Health, Mortality Link Especially Pronounced in Black Women Yael L. Maxwell March 17, 2023
News Daily News Mediterranean Diet’s CV Benefits Extend to Women: Meta-analysis Caitlin E. Cox March 15, 2023
News Conference News ACC 2023 ‘Causal AI’ May Help Guide Specific Actions to Reduce CVD Risk Caitlin E. Cox March 10, 2023
News Conference News ACC 2023 Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes Michael O'Riordan March 04, 2023